搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salinibacter ruber Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP651741SBAB
CSB-EP651741SBAB
CSB-BP651741SBAB
CSB-MP651741SBAB
CSB-EP651741SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber ATP-dependent Clp protease proteolytic subunit 2 (clpP2) CSB-YP651742SBAB
CSB-EP651742SBAB
CSB-BP651742SBAB
CSB-MP651742SBAB
CSB-EP651742SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Thymidine kinase (tdk) CSB-YP651743SBAB
CSB-EP651743SBAB
CSB-BP651743SBAB
CSB-MP651743SBAB
CSB-EP651743SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Anhydro-N-acetylmuramic acid kinase (anmK) CSB-YP651744SBAB
CSB-EP651744SBAB
CSB-BP651744SBAB
CSB-MP651744SBAB
CSB-EP651744SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (gpmI), partial CSB-YP651745SBAB
CSB-EP651745SBAB
CSB-BP651745SBAB
CSB-MP651745SBAB
CSB-EP651745SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber 3-isopropylmalate dehydrogenase (leuB) CSB-YP651746SBAB
CSB-EP651746SBAB
CSB-BP651746SBAB
CSB-MP651746SBAB
CSB-EP651746SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Release factor glutamine methyltransferase (prmC) CSB-YP651747SBAB
CSB-EP651747SBAB
CSB-BP651747SBAB
CSB-MP651747SBAB
CSB-EP651747SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Fructose-1,6-bisphosphatase class 1 2 (fbp2) CSB-YP651748SBAB
CSB-EP651748SBAB
CSB-BP651748SBAB
CSB-MP651748SBAB
CSB-EP651748SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Glutamate--tRNA ligase (gltX) CSB-YP651749SBAB
CSB-EP651749SBAB
CSB-BP651749SBAB
CSB-MP651749SBAB
CSB-EP651749SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber 50S ribosomal protein L11 (rplK) CSB-YP651750SBAB
CSB-EP651750SBAB
CSB-BP651750SBAB
CSB-MP651750SBAB
CSB-EP651750SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Tryptophanase (tnaA) CSB-YP651751SBAB
CSB-EP651751SBAB
CSB-BP651751SBAB
CSB-MP651751SBAB
CSB-EP651751SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (ispF) CSB-YP651752SBAB
CSB-EP651752SBAB
CSB-BP651752SBAB
CSB-MP651752SBAB
CSB-EP651752SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Malate dehydrogenase (mdh) CSB-YP651753SBAB
CSB-EP651753SBAB
CSB-BP651753SBAB
CSB-MP651753SBAB
CSB-EP651753SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Thiamine-phosphate synthase (thiE) CSB-YP651754SBAB
CSB-EP651754SBAB
CSB-BP651754SBAB
CSB-MP651754SBAB
CSB-EP651754SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP651755SBAB1
CSB-EP651755SBAB1
CSB-BP651755SBAB1
CSB-MP651755SBAB1
CSB-EP651755SBAB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber 50S ribosomal protein L27 (rpmA) CSB-YP651756SBAB
CSB-EP651756SBAB
CSB-BP651756SBAB
CSB-MP651756SBAB
CSB-EP651756SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber CinA-like protein (SRU_1303) CSB-YP651757SBAB
CSB-EP651757SBAB
CSB-BP651757SBAB
CSB-MP651757SBAB
CSB-EP651757SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Thiazole synthase (thiG) CSB-YP651758SBAB
CSB-EP651758SBAB
CSB-BP651758SBAB
CSB-MP651758SBAB
CSB-EP651758SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) CSB-YP651759SBAB
CSB-EP651759SBAB
CSB-BP651759SBAB
CSB-MP651759SBAB
CSB-EP651759SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinibacter ruber DNA-directed RNA polymerase subunit alpha (rpoA) CSB-YP651760SBAB
CSB-EP651760SBAB
CSB-BP651760SBAB
CSB-MP651760SBAB
CSB-EP651760SBAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>